PubMed HealthSearch

PubMed · 2475397

Fluorescence crossmatch testing.

Abstract

This paper is a short evaluation of the crossmatch testing performed with the fluorescence cytotoxic test to detect HLA compatibility of the platelet concentrates administered. From a total of 1,500 reactions between HLA incompatible donors and recipients mutual agreement was achieved in 96% of the reactions. HLA compatibility between donors and recipients was achieved in 97.31%. Advantages of the fluorescence method were stressed out.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Prazák. 1989. Fluorescence crossmatch testing.. https://pubmed.ncbi.nlm.nih.gov/2475397/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The use of colony-stimulating factors in primary hematologic disorders.

BACKGROUND: The cloning of the human colony-stimulating factors (CSF), granulocyte CSF, granulocyte-macrophage CSF, and interleukin-3 has led to their use in a variety of clinical settings. RESULTS: These CSF have been used successfully to raise neutrophil counts and prevent or control infection in patients with neutropenia due to primary hematologic disorders. Their effects on platelet and erythrocyte counts have been modest; occasional patients have multilineage improvement in hematopoiesis. CONCLUSIONS: The CSF can be given for several months at effective and tolerable doses. Their long-term efficacies and toxicities remain to be elucidated, and the optimal dose and dosing schedule to be used for each indication are not defined currently. Although the CSF can improve hematopoiesis in patients with primary hematologic disorders, they are not curative.

Anemia, Aplastic